Expert Information
Tips, insights, and expert information to help you manage brain and eye disease.
Our tools will help you understand and manage symptoms, treatment, and prevention of these diseases.
Current treatments for wet age-related macular degeneration (AMD) require eye injections approximately every 4 – 8 weeks. Learn about a potential new treatment that may require less frequent injections.
Learn about the most recent medical advances in electronic retinal implants for vision restoration.
Learn how glasses can help with macular degeneration (AMD) and what types of special glasses are best for different stages of AMD.
A retina specialist answers common questions about injection treatments for wet macular degeneration.
Learn why stem cell replacement therapy for dry macular degeneration is showing promise.
Read about the exciting new research for treatment of dry age-related macular degeneration.
Drusen are small protein and lipid deposits under the retina of the eye. They are the defining feature of age-related macular degeneration. Learn about diagnosis and risks.
Patients often ask if their medications affect the risk of vision loss from age-related macular degeneration (AMD). One class of medications can lead to more severe vision loss in people with the wet form of the disease, and another class of drugs may have a beneficial effect.
Learn about Charles Bonnet syndrome, which can cause visual hallucinations in people living with macular degeneration, glaucoma, or cataracts.
People suffering from age-related macular degeneration (AMD) can lose some or all of their central vision. The disease rarely affects the side (peripheral) vision, and for those whose central vision is affected, in some circumstances vision may be regained.
